Catherine E. Muehlenbein

Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

Crystal Pike, Howard G. Birnbaum, Catherine E. Muehlenbein et al. · Chemotherapy Research and Practice · 2012 · 204 citations · Full text

Medicine, Oncology, Pharmacoeconomics +15

Effectiveness of Personal Protective Measures to Prevent Lyme Disease

Marietta Vázquez, Catherine E. Muehlenbein, Matthew Cartter et al. · Emerging infectious diseases · 2008 · 173 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Cost-Effectiveness of Pemetrexed as First-Line Maintenance Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer

Robert W. Klein, Ron Wielage, Catherine E. Muehlenbein et al. · Journal of Thoracic Oncology · 2010 · 71 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +9

Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001

Caroline E. McCoach, Christian Rolfo, Alexander Drilon et al. · Journal of Thoracic Oncology · 2022 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Neutropenia-Related Costs in Patients Treated with First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Michael E. Stokes, Catherine E. Muehlenbein, Martin Marciniak et al. · Journal of Managed Care Pharmacy · 2009 · 51 citations · Full text

Medicine, Geriatric Medicine, Oncology +17